Skin toxic effects of polyethylene glycol-coated liposomal doxorubicin

Archives of Dermatology

Volumn 136, Issue 12, 2000, Pages 1475-1480

  Lotem, M ^a   Hubert, A ^a   Lyass, O ^a   Goldenhersh, M A ^a   Ingber, A ^a   Peretz, T ^a   Gabizon, A ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; LIPOSOME; MACROGOL;

ALOPECIA; ARTICLE; BREAST CANCER; CLINICAL FEATURE; DISEASE SEVERITY; DRUG COATING; DRUG ERUPTION; DRUG FORMULATION; EXTRAVASATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTPATIENT CARE; PRIORITY JOURNAL; PROSTATE CANCER; RASH; SKIN MANIFESTATION; STOMATITIS;

EID: 0034529887     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.136.12.1475     Document Type: Article

References (21)

1. Liposome circulation time and tumor targeting: Implications for cancer chemotherapy
2. Liposomal-entrapped doxorubicin: An active agent in AIDS-related Kaposi's sarcoma
3. Phase II study of liposomal doxorubicin in refractory ovarian cancer: Antitumor activity and toxicity modification by liposomal encapsulation
4. The anthracycline antineoplastic drugs
5. Liposomal doxorubicin: Antitumor activity and unique toxicities during two complementary phase I studies
6. Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethyleneglycol coated liposomes
7. Doxil (Celyx): An exploratory study with pharmacokinetics in patients with hormone-refractory prostate cancer
8. Correlation of toxicity with pharmacokinetics of pegylated liposomal doxorubicin (Doxil) in metastatic Breast cancer
9. Immediate and long-term toxicity of adjuvant chemotherapy regimens containing doxorubicin in trials at MD Anderson Hospital and Tumor Institute
10. Continuous venous infusion of doxorubicin in advanced sarcomas
11. Chemotherapy-induced cutaneous reactions
12. Relationship of dose intensity to the induction of palmar-plantar erythrodysesthesia by pegylated liposomal doxorubicin in dogs
13. Treatment of advanced breast cancer with sterically stabilized liposomal doxorubicin: Results of a multicenter phase II trial
14. Initial clinical trial of TLC D-99 (doxorubicin encapsulated in liposomes)
15. Mucocutaneous reactions to chemotherapy
16. Effect of maintenance chemotherapy in childhood on numbers of melanocytic naevi
17. Lack of vesicant injury following extravasation of liposomal doxorubicin
18. The cutaneous histopathology of chemotherapeutic reactions
19. Long-circulating liposomes for drug delivery in cancer therapy: A review of biodistribution studies in tumor-bearing animals
20. Mechanism of stealth liposome accumulation in some pathological tissues
21. Toxicity of fluorouracil in patients with advanced colorectal cancer: Effect of administration schedule and prognostic factors